PharmAthene Inc (NYSE MKT LLC:PIP)

Data as of 12:00am ET
 +0.03 / +1.72%
Today’s Change
Today|||52-Week Range
Commercial Services
Miscellaneous Commercial Services

Company Description

PharmAthene, Inc. operates as a biodefense company, which is engaged in the development and commercialization of medical countermeasures against biological and chemical threats. Its product development programs include SparVax, a second generation recombinant protective antigen anthrax vaccine; Valortim, a fully human monoclonal antibody for the prevention and treatment of anthrax infection; and Recombinant BChE, countermeasures for nerve agent poisoning by organophosphorous compounds, including nerve agents and pesticides. The company was founded in March 2001 and is headquartered in Annapolis, MD.

Contact Information

PharmAthene, Inc.
1 Park Place
Annapolis Maryland 21401
P:(410) 269-2600
Investor Relations:
(410) 269-2610



Individual stakeholders40.83%
Mutual fund holders3.51%
Other institutional25.74%

Top Executives

Eric I. RichmanPresident, Chief Executive Officer, COO & Director
Linda L. ChangChief Financial Officer & Senior Vice President
Arthur Y. ElliottChief Scientific Officer
Jeffrey M. JonesVice President-Corporate Development
Stacey JurchisonDirector-Corporate Communications

To view my watchlist

Not a member yet?

Sign up now for a free account
Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer Morningstar: © 2014 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2014 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2014. All rights reserved. Most stock quote data provided by BATS.